Education

Peer-reviewed research supporting compounded therapies

Compounding pharmacy allows healthcare providers to customize medications for individual patient needs -- adjusting dosages, combining ingredients, or changing delivery forms. The research below highlights some of the evidence behind the therapies we compound.

Pain Management

Low-dose naltrexone for the treatment of fibromyalgia

Younger J, Noor N, McCue R, Mackey S — Arthritis & Rheumatism (2013)

Participants receiving 4.5 mg daily of naltrexone experienced significantly greater reduction of baseline pain compared to placebo (28.8% vs 18.0% reduction). The treatment also improved life satisfaction and mood, with 32% of participants meeting response criteria vs 11% during placebo.

Read Full Study
Crohn's Disease

Low-dose naltrexone therapy improves active Crohn's disease

Smith JP, Stock H, Bingaman S, Mauger D, Rogosnitzky M, Zagon IS — American Journal of Gastroenterology (2007)

This pilot trial demonstrated that low-dose naltrexone (4.5 mg daily) produced significant clinical improvements in patients with active Crohn's disease. 89% of patients showed therapeutic response, with 67% achieving full remission.

Read Full Study
Smoking & Alcohol Cessation

Smoking and Opioid Detoxification: Behavioral Changes and Response to Treatment

Mannelli P, Wu LT, Peindl KS, Gorelick DA — Nicotine & Tobacco Research (2013)

Patients who smoked during inpatient treatment experienced significantly higher opioid craving and lower completion rates. The combination of very low-dose naltrexone with clonidine proved most effective at reducing both smoking behavior and cigarette craving.

Read Full Study
Anti-Aging

The Potentials of Methylene Blue as an Anti-Aging Drug

Xue H, Thaivalappil A, Cao K — Cells (2021)

This review examines methylene blue (MB), an FDA-approved compound with antioxidative properties, as a potential therapeutic agent for age-related conditions. MB improves mitochondrial function and reduces reactive oxygen species production, demonstrating promise in treating neurodegeneration, memory loss, skin aging, and progeria.

Read Full Study
Weight Loss

Efficacy of Semaglutide in a Subcutaneous and an Oral Formulation

Meier JJ — Frontiers in Endocrinology (2021)

Clinical trials in the SUSTAIN and PIONEER programs demonstrated that semaglutide effectively reduces HbA1c levels and body weight across both subcutaneous and oral formulations. Once-weekly subcutaneous semaglutide 1.0 mg reduced HbA1c by 1.5-1.8%, with oral formulations achieving 1.0-1.4% reductions.

Read Full Study
Compounding

The Role of Pharmaceutical Compounding in Promoting Medication Adherence

Carvalho M, Almeida IF — Pharmaceuticals (Basel) (2022)

This review examines how customized pharmaceutical compounding addresses medication non-adherence by tailoring medicines to individual patient needs. The authors propose patient-centric compounding design methodology with applications in pediatric and geriatric populations, orphan drug treatment, and managing polypharmacy.

Read Full Study
Men's Health

Androgen Replacement

Sizar O, Leslie SW, Pico J — StatPearls (2023)

This chapter examines testosterone replacement therapy for men with hypogonadism. It covers clinical indications, administration methods including gels and injections, monitoring protocols, and the importance of distinguishing between primary and secondary hypogonadism alongside cardiovascular safety considerations.

Read Full Study
Men's Health

Testosterone Therapy for Late-Onset Hypogonadism Using Compounded Testosterone 0.5-20% Topical Gels

Banov D, Biundo B, Ip K, Shan A, Banov F, Song G, Carvalho M — Pharmaceutics (2024)

This multidisciplinary study evaluated compounded testosterone topical gels through clinical case assessment, laboratory permeation testing, and stability analysis. A 70-year-old patient on 5% testosterone gel showed symptom improvement and optimal serum levels, with formulations remaining stable for six months.

Read Full Study
HRT

Hormone Replacement Therapy

Harper-Harrison G, Carlson K, Shanahan MM — StatPearls (2024)

This chapter examines HRT as treatment for moderate-to-severe vasomotor menopausal symptoms. It covers estrogen and progesterone formulations, administration routes (oral, transdermal, vaginal), evidence-based dosing, contraindications, and monitoring protocols contextualized within Women's Health Initiative trial findings.

Read Full Study

What is Compounding Pharmacy?

Compounding is the practice of creating personalized medications tailored to the specific needs of individual patients. Unlike mass-produced drugs, compounded medications can be customized in strength, dosage form, and ingredients.

This is especially important for patients who need medications that are no longer commercially available, require allergy-free formulations, or need alternative delivery methods like topical creams and solutions.

At T&H Pharmacy, our team of licensed pharmacists and technicians compound medications under strict quality controls in our state-of-the-art facility. Every formulation is prepared to meet USP standards.

We specialize in dermatology, men and women's health (including bioidentical HRT), veterinary, pain management, and more!